MedPath

*Evaluating the feasibility of intraluminal oxygen administration at the site of the anastomosis in patients who underwent an esophagectomy; a pilot study*

Completed
Conditions
esophageal cancer
10017991
10017998
Registration Number
NL-OMON52912
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
19
Inclusion Criteria

- Patients with esophageal cancer scheduled for a minimal invasive esophageal
resection with an intrathoracic anastomosis
- Aged 18 years or older.
- Signed informed consent.

Exclusion Criteria

- Known nasopharynx abnormalities preventing nasogastric tube insertion
- Salvage surgery after *definitive chemo-radiotherapy*
- Unable to provide informed consent
- Patient being illiterate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>- To assess the successful placement of the intervention nasogastric oxygen<br /><br>delivery tube.<br /><br>- To assess the tolerance and feasibility of the intervention nasogastric<br /><br>oxygen delivery tube for oxygen administration during the first 5 days after<br /><br>surgery.<br /><br>- To assess the amount of discomfort patients have of the extra nasogastric<br /><br>tube.<br /><br>- To monitor the intraluminal pressure via the oxygen delivery tube and<br /><br>keep it under 20 mmHg</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- To explore the safety of the administration of intraluminal oxygen via an<br /><br>extra nasogastric tube at the site of the anastomosis in patients who underwent<br /><br>an esophagectomy (bleeding, gastric tube distention).<br /><br>- To what extent does the administration of intraluminal oxygen at the site of<br /><br>the anastomosis effect theanastomotic leak rate in patients who underwent an<br /><br>esophagectomy?(normal rate 20%)</p><br>
© Copyright 2025. All Rights Reserved by MedPath